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Abstract 
Novel derivatives of benzopyran-2-ones are synthesized by catalytic condensation reaction. 4-(3-Hydroxy-2-
pyridinylamino)- 3-nitro-2H-[1]-benzopyran-2-one  4a,  4-(4-methyl-3-nitro-2-pyridinylamino)-3-nitro-2H-[1]-
benzopyran-2-one,  4b  and 4-(pyrimidinylamono)-3-nitro-2H-[1]-benzopyran-2-ones  4(c, d) are synthesized by 
condensation of 4-Chlor-3-nitro-2H-[1]-benzopyran-2-one  2   and corresponding heteroarylamines  3(a-d ) 
under reflux reaction conditions. Alkali hydrolysis of  4(a-d ) afforded the 2-hydroxy-ω -nitroacetophenone  5. 
Structural characterization of the synthesized products is done on the basis of spectrometric data. Antibacterial 
activity of the compounds 4(a-d) against S. aureus, E. coli and Klebsiella was examined by measuring the 
inhibition zones around the disks marked with the corresponding product solutions in N,N-DMF concentration 2 
mg/mL , 4 mg/mL and 6 mg/mL. Compounds 4a and 4c  have shown significant antibacterial activity against S. 
aureus, compounds 4b and 4d exhibited significant activity  against E. coli whereas compound 4d was more 
active against Klebsiella.  
Keywords: Thiazolidin-4-one; benzopyran-2-one; condensiation;  antibacterial; inhibition zones. 
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1. Introduction 
Coumarine derivatives are very important natural extended compounds. Most of them are isolated from various 
plants [1,2] .They  have been extensively investigated for a long time by many chemists [3,4]. Most of them 
have been reported [5,6] in the literature. Many of coumarinic analogues exhibited also antioxidant [7-9], anti-
tubercular [10] and cytotoxic activity [11]. They exhibited antifungal [12,13] , antibacterial [14] , antimicrobal 
[15-17] and antimalarial activity [18].  Some of substituted coumarinic analogues with expressed antioxidant 
[19,20], cytotoxic[21], anti-tubercular [22], sedative, analgesic and hepatoprotective [23-25] activity are 
reported also. For this reason, many of them have found widespread usage in pharmacies.  Furthermore some of 
the exhibited both antibacterial and  antioxidant activity[26]. Moreover the biological importance of coumarine 
derivatives resulted in much interest in their synthesis. Unfortunately isn’t known any general route for 
preparation of these derivates.  According to that they are the object of studying and synthesis for many 
investigators.  
In continuation of our previous studies on the synthesis of various coumarine derivatives by condensation 
reactions [27,28], in this study we report about preparing and structuralcharacterization of some new substituted  
pyridinylamino- and pyrimidinylamino-2H-[1]-benzopyran-2-ones by condensation of 4-Chloro-3-nitro-2H-[1]-
benzopyran-2 one and substituted pyridinyl- and pyrimidinylamines. In continuing, alkali hydrolysis of the 
synthetized products is described. Antibacterial activitiy of condensing products are also reported. 
2. Methods and materials  
All experiments were carried out in acetonitrile as an aprotic solvent, under reflux reaction conditions. 
Following of the reactions were monitored by TLC using Merck Kieselgel-60 (F-254) on a benzene: toluene: 
glac. acetic acid bath (ratio 75 : 15 : 10 by volume, visualization on a UW lamp). Purification of products was 
done by crystallization from various solvents. Melting points were measured on a parafine bath in open capilary 
tubes and values are uncorrected. 1H-NMR spectra were obtained in DMSO on UNITY plus-500 “NMR 1” 
Spectrometer. Chemical shifts are reported in parts per million (ppm) downfield from tetramethylsilane as an 
internal standard (δ0,00). IR spectra were recorded in KBr discs on a Shimadzu FTIR 8400S Spectrometer with 
4cm-1 resolution. Microanalyses were performed on a Perkin-Elmer 240 B CHN analyser. Antibacterial activity 
of compounds were investigated applying the discs method (d =5,5 mm, max. capacity 10 μg). The discs were 
wetted with N,N-DMF solutions of the synthetyzed compounds (2 mg/mL, 4 mg/mL and 6 mg/mL). 
2.1. 4-Heteroarylamino-3-nitro-2H-[1]-benzopyran-2-ones  4(a-d)    General procedure 
In a typical reaction, 4-Chloro-3-nitro-2H-[1]-benzopyran-2-one  2 , equimolar amount of heteroaryalmine 3(a-
d) and catalytic amount  of triethylamine in acetonitrile are refluxed on  a water bath for 2 – 8 h. The mixture 
was filtered under vacuum and the crude product purified by crystallization. 
2.2. 4-(3-hydroxy-2-pyridinylamino)-3-nitro-2H-[1]-benzopyran-2-one,   4a 
To a solution of 2-amino-3-hydroxypyridine 3a  (0,5g ; 4,6 mmole) in acetonitrile (40 mL), 0,2 mL of 
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triethylamine was added. After that 0,27g , (1,2mmole) of  4-Chloro-3-nitro-2H-[1]-benzopyran-2-one  2 was 
added. The reaction mixture was refluxed for 5 h  under  vigorously stirring and then monitored by TLC. After 
that the mixture was cooled  and yellow-orange crystalline product was filtered under vacuum, then washed with 
a 2 mL portion of methanol. Crystallization of residue from methanol gave 0,97g (72%) product 4a. mp = 208 – 
210 ˚C. IR: 3399 cm-1,  3260 cm-1,   3071 cm-1,   1696 cm-1,  1612 cm-1,  1539 cm-1,  1459 cm-1,   1373 cm-1,  
1296 cm-1,   1204 cm-1,  1120 cm-1,  805 cm-1, 762 cm-1,   605 cm-1.  1H-NMR  : δ8,80 (s,  1H),  δ 7,45 – 7,60 
(m, 3H),  δ 7,20 – 7,30  ( m, 4H),   δ 5,5  ( s, 1H). Anal: Calculated for C14H9N3O5: (C, 56,17%), (H, 3,03%),     
(N, 14,04%), (O, 28,76%).  Found: (C, 56,22%), (H, 3,04%), (N, 14,03%).   
2.3. 4-(4-methyl-3-nitro-2-pyridinylamino)-3-nitro-2H-[1]-benzopyran-2-one,  4b 
A mixture of   4-Chloro-3-nitro-2H-[1]-benzopyran-2-one  2  (0,5 g, 2,26 mmole) and  4-methoxy-2-
aminobenzothiazole  3b  (0,35 g, 2,26 mmole), containing triethylamine (three drops) in acetonitrile (20 mL) 
was refluxed under vigorously stirring  for 8 h. The mixture was cooled in an ice bath for 1 h , then filtered off 
under vacuum and washed with a portion of 1 mL of absolute ethanol. Crystallization from methanol gave 0,4 g   
(52%) of brown crystaline product 4b. mp = 240 -242 ˚C. IR:  3298 cm-1,  3186 - 3097 cm-1,  1715 cm-1,  1665 
cm-1,   1625 cm-1,   1610 cm-1,  1548 cm-1 1529 cm-1,   1459 cm-11416 cm-1,  1368 cm-1,   1294 cm-1,   1243 cm-1,  
1211 cm-1 1083 cm-1,   1005 cm-1 902 cm-1,  766 cm-1 672 cm-1,   550 cm-1. 1H-NMR  :     δ9,20 (s,  1H),    δ7,60 
( d, 2H ),   δ7,40 – 7,25 (m, 4H ),   δ2,10 ( s,  3H) . Anal:   Calculated for C15H10N4O6 :  (C, 51,12%), (H, 
2,86%), (N, 15,91%), (O, 30,21%). Found:  (C, 50,99%), (H, 2,92%), (N, 16,01%).  
2.4. 4-(4-hydroxy-6-metyl-2-pyrimidinylamino)-3-nitro-2H-[1]-benzopyran-2-one, 4c   
A mixture of   4-Chloro-3-nitro-2H-1-benzopyran-2-one  2  (0,22g, 1 mmole) and  2-amino-4-hydroxy-6-
metylpyrimidine  3c  (0,12 g,  1 mmole), containing triethylamine (two drops) in acetonitrile (10 mL) was 
refluxed on a water bath . A CaCl2 guard tube was mounted and the reaction mixture was allowed to stirr under 
reflux for 2 h, then cooled to room temperature and the yellow crystalline product was formed. The mixture was 
filtered under vacuum. The residue washed with 1mL of acetonitrile. Crystallization from methanol gave 0,21g   
(68%) of yellow crystalline product 4d. mp = 217˚C. IR:  3153 cm-1,  2997 cm-1,   2355 cm-1,   1712 cm-1,  1647 
cm-1,  1598 cm-1, 1559 cm-1 1438 cm-1,   1354 cm-1,  1184 cm-1, 762 cm-1. 1H-NMR  :  δ11,76 (s,  1H), δ 7,85  ( 
d, 1H),  δ 7,82 (t, 1H),  δ 7,35-7,44  ( m, 3H),   δ 5,54  (s, 1H),  δ 2,08  ( s,3H). Anal: Calculated for 
C14H10N4O5: (C, 53,49%), (H, 3,21%),    (N, 17,83%). Found: (C, 53,66%), (H, 3,31%), (N, 17,92%).   
2.5. 4-(6-hydroxy-2-mercapto-4-pyrimidinylamino)-3-nitro-2H-[1]-benzopyran-2-one, 4d 
To a 4-amino-6-hydroxy-2-mercaptopyrimidine monohydrat 3d ( 0,22g,  1,36 mmole ) in 15 mL of acetonitrile 
solution, triethylamine (4 drops) and 4-Chloro-3-nitro-2H-[1]-benzopyran-2-one  2  ( 0,3g,  1,36 mmole )  was 
added. The mixture was heated slightly and refluxed for 12 h at 60 – 70 ˚C then cooled in an ice bath. The crude  
product was filtered under vacuum, washed  with 2 x 1 mL of acetonitrile and dried. Crystallization from 
tetrehydrofurane gave 0,29 g  ( 66%) of crystalline product  4d,  mp = 202 – 204 ˚C. IR:   3425 cm-1,  3294 cm-
1,  3186 cm-1,  3097 cm-1,   1715 cm-1,   1665 cm-1,  1610 cm-1 1548 cm-1,   1459 cm-1,  1368 cm-1,   1294 cm-1,   
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1181 cm-1,  902 cm-1 766 cm-1. 1H-NMR:   δ10,55 (s,  1H),    δ7,80 ( d, 1H ),   δ7,50 (t, 2H ),   δ7,20 ( d,  2H) ,   
δ7,10 ( s, 1H ),   δ5,60 (s, 1H ),   δ2,20 ( s,  1H). Anal: Calculated for C13H8N4O5S:  (C, 46,98%), (H, 2,43%), 
(N, 16,86%), (O, 24,09%), (S, 9,64%). Found: (C, 47,11%), (H, 2,36%), (N, 16,67%), (S, 9,50%).  
2.6. 2-Hydroxy-ω-nitroacetophenone  5 
Heteroarylamino-2H-1-Benzopyran-2-ones 4a , 4b , 4c and 4d (2 mmole) was dissolved in 10 mL 5% natrium 
hyodoxide water solution and heated at 95˚C for 1 h. The reaction mixture was cooled and acidified with dil. 
hydrochloric acid and ice to pH = 1. The crude product was filtered off and washed with 3 x 2 mL of water. 
Crystallization from ethanol gave  0,3 g,  (84%) of product  5. IR:   3400 cm-1,  3085 cm-1,  2950 cm-1,  1637 
cm-1,   1613 cm-1,   1560 cm-1,  1449 cm-1 1369 cm-1,   754 cm-1.  mp=96˚C. 1H-NMR:   δ12,92   (s,  1H),    
δ11,41   ( s, 1H ),   δ7,87   (d, 1H ),   δ7,64  ( d,  1H),  δ7,18  ( q,  2H ),  δ 6,28  ( s, 2H ). Anal: Calculated for 
C8H7NO4: (C, 53,04%), (H, 3,89%), (N, 7,74%), (O, 35,32%). Found: (C, 52,94%), (H, 4,18%), (N, 7.72%). 
3. Results and discussion 
We previously reported that catalyst condensation of 4-Chloro-3-nitro-2H-[1]-benzopyran-2 one 2  with various 
heterocyclic amines  gives corresponding 4-Heteroarylamino-3-nitro-2H-[1]-benzopyran-2-ones[27, 28]. 
According to our investigation we now report that 4-Chloro-3-nitro-2H-[1]-benzopyran-2 one 2  react readily 
with various heteroarylamines to form the corresponding 4-Heteroarylamino-3-nitro-2H-[1]-benzopyran-2-ones  
4(a-d). By reacting of equimolar amounts of 4-hydroxy-3-nitro-2H-[1]-benzopyran-2-one  1, 
phosphooxychloride and N,N-dimethylformamide[38], 4-chloro-3-nitro-2H-[1]-benzopyran-2 one  2  was 
obtained in 92% yield. Thus product  2  was subjected to condensation with various substituted pyridinyl- and 
pyrimidinylamines  3(a-d) in acetonitrile under reflux to yield the respective 4-Heteroarylamino-2H-[1]-
benzopyran-2-ones 4(a-d),  (scheme 1).  
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Figure 4 
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By condensation of  2  and 2-amino-3-hydroxypyridine 3a, 4-(3-hydroxy-2-pyridinylamino)-3-nitro-2H-[1]-
benzopyran-2-one  4a is obtained in 72% yield. By similar treatment of  2  and 2-amino-3-nitro-4-
methylpyridine 3b  under reflux in acetonitrile solution gave 4-(3-nitro-4-methyl-2-pyridinylamino)-3-nitro-2H-
[1]-benzopyran-2-one 4b  in  52% yield. On the other hand compound  2  reacts with 2-amino-4-hydroxy-6-
methylpyrimidine  3c  and  4-amino-6-hydroxy-2-mercaptopyrimidine  3d  in the presence of catalytic amount 
of triethylamine to afford 4-(4-hydroxy-6-methyl-2-pyrimidinylamino)-3-nitro-2H-[1]-benzopyran-2-one  4c  
and  4-(-6-hydroxy-2-mercapto-4-pyrimidinylamino)-3-nitro-2H-[1]-benzopyran-2-one  4d  respective. By 
alkali hydrolysis of  the products 4a , 4b , 4c and 4d , everyone gave 2-hydroxy-ω-nitroacetophenone 5 . It is 
believe that the formaton of product 5  followed by tautomerization of precursors resulting to imine formation, 
and in next step by imine hydrolysis and decarboxylation. The structure of the products were determined from 
their IR, 1H-NMR and 13C –NMR spectra and their elemental analysis. 
3.1. IR spectrum of 4a showed the apsorption as a sharp peak at 3260 cm-1 responsible for υNH stretching, and a 
band at about 3390 cm-1 characteristic for υOH group of pyridine system. We may suppose that appearance of 
this absorption mode as a inflexive form may be as a consequence of possibility of intramolecular hydrogen 
bonding association of this group. The υCH stretching vibration  from aromatic ring were appeared at 3071 cm-
1. A sharp peak at 1696 cm-1 and peaks at 1612 cm-1 and 1539 cm-1 responsible for υCO str., υC=N and υC=C 
(ar) were appeared. Two absorption at 1459 cm-1 and 1373 cm-1 attributable to υNO2 (as) and υNO2 (sym), and 
the  δCH (out of plane) mode at 762 cm-1 also were observed. The υC-O of  six-membered lactonic system is 
assigned at 1296 cm-1, whereas the mode at 1024 cm-1 resulted from υC-O of hydroxy group. The absorption 
mode at 1697 cm-1 responsible for  υCO vibration was assigned to low frequencies, may be as a result of 
decreasing of the respective force constant and the bond order. 
3.2. The formation of 4b is identified from 1H-NMR (DMSO) spectrum where is appeared the absorption as a 
multiplet at  δ7,2-7,6 ppm ( responsible for aromatic protons). The spectrum  also displayed a singlet at δ2,1 
ppm (s, 3H, assigned for CH3), and a singlet at δ9,2 ppm  (s. 1H responsible for NH proton apsorption). In the 
IR spectrum of 4b a characteristic absorption appeared at 3294 cm-1 due to typical υNH stretching of secondary 
amines. IR spectrum of this product also showed the absorption modes at 3186 cm-1  and at 3097cm-1 responsible 
for υCH stretching  absorption of aromatic ring and  and      υCH stretching  of methyl group. An absorption at 
1715 cm-1 attributable to typical υCO of unsaturated six-membered lactones was observed. The sharp peaks at 
1665 cm-1 and 1625 cm-1 which are responsible for aromatic υC=N and υC=C vibration are also appeared. At 
1548 cm-1 and 1294 cm-1 for stretching υNO2 (as) and υNO2 (sym), and at 766 cm-1 for bending δCH (ar) was 
also appeared. 
3.3. Formation of 4c is identified from 1H-NMR ( DMSO) spectrum where the absorption as a proton doublet at  
δ7,85 ppm responsible for H-5 and a proton triplet at δ7,82 ppm ( H-7) is appeared. The spectrum  also 
displayed a signal at δ11,76 ppm (s, 1H, assigned for NH),  and a multiplet signal  for aromatic H-6, H-8 and H-
5’ protons at   δ7,35-7,44 ppm. A signal at δ5,54 ppm  is appeared as function of hydroxy proton absorption and 
a proton singlet at  δ 2,08 ppm  resulted from methyl proton vibration. 13C-NMR spectrum of 4c showed  
characteristic  absorptions responsible for respective 14 carbon atoms. In the IR spectrum of 4c a characteristic 
absorption at 3447 cm-1 due to typical υNH stretching of secondary amines is appeared. IR spectrum of this 
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product also showed the absorption modes at 3153 cm-1, 2997 cm-1  and 2841 cm-1 responsible for υOH 
stretching absorption, υCH stretching of aromatic ring and υCH stretching of methyl group. An absorption at 
1712 cm-1 attributable to typical υCO of unsaturated lactonic ring is observed. Signals  which are responsible for 
aromatic υC=N and υC=C vibrations are appeared at 1647 cm-1 and 1598 cm-1.  At 1517 cm-1 and 1354 cm-1  
absorptions for the stretching υNO2 (as) and υNO2 (sym), and at 762 cm-1 for the bending δCH (oop) of 
aromatic system were also appeared. 
3.4. IR spectrum of 4d showed two absorptions at 3425 cm-1  and 3294 cm-1 responsible for υNH (str) and υOH 
(str) vibrations. Signals at  3186 cm-1  and at 3097 cm-1 are  characteristic for stretching aromatic  υCH (as) and  
υCH (sym) vibrations. A sharp peak at 1715 cm-1 and peaks at 1665 cm-1 and 1610 cm-1 responsible for υCO 
str., υC=N and υ C=C (ar) were appeared. Two absorption at 1548 cm-1 and 1368 cm-1 attributable to υNO2 (as) 
and υNO2 (sym), and the  δCH bending (oop) mode at 766 cm-1 also were observed. 
3.5. The characteristic modes of product 5 appeared at 3080 – 3400cm-1 (a broad band) and 2950 cm-1 which are 
responsible for υOH stretching, υOH (chelat), aromatic υCH  and methylene υCH absorptions. The 
characteristic peak derived from lactonic carbonyl as a result of intramolecular hydrogen bonding  is muved 
down at 1637 cm-1. IR spectrum of the hydrolysis product 5 also showed the  bands at 1560 cm-1 for υ C=C (ar), 
1449 cm-1 for υ NO2 (as), 1369 cm-1 for υNO2 (sym) and 754 cm-1 aromatic δ CH out of plane. In addition to 
that, the elementary analysis of obtained products 4 (a-d) indicated in favour of described structures. 
4. Antimicrobial activity 
In contionuing to that we examined the antibacterial activity of synthetized compounds on the basis of Kirby-
Bayer-s method [29]. Our investigation is directed toward testing their activity against S. aureus, E. coli and 
Klebsiella. Applying the discs method we meassured diameters of the inhibition zone around discs which are 
previously marked with N,N-DMF solutions of compounds, 2mg/mL,  4mg/mL and 6mg/mL. Obtained results 
are summarized bellow. From thesse observations resulted that these derivates were shown moderate to high 
activity against S. aureus, E. coli and Klebsiella. Compounds 4a and 4c  are more active against S. aureus. 
Emphatic activity against E. coli exhibited compound 4b, whereas 4d  was more active against Klebsiella. Exept 
bactericide activity against S. aureus, compounds 4a and 4c as well appeared bacteriostatic activity in low 
concentrations. Moreower, bacteriostatic activity against Klebsiella exibited compound 4a in low 
concentrations. In general increasing of concentration causes high  activity against these microorganisms. 
 
Figure 1: Graphical presentation of inhibition zone diameter (mm) against S. aureus. 
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Figure 2: Graphical presentation of inhibition zone diameter (mm) against E. coli. 
 
Figure 3: Graphical presentation of inhibition zone diameter (mm) against klebsiella. 
5. Conclusions 
Novel 4-substituted pyridinylamino- and pyrimidinylamino-3-nitro-2H-[1]-benzopyran-2-one derivates 4a-d are 
synthesized in the moderate and high yield via condensation reaction of 4-chloro-3-nitro-2H-[1]-benzopyran-2-
one and corresponding heteroarylamines. From thesse resoults we may conclud that the tested compounds 
showed considerable activity against S. aureus, E. coli and Klebsiella. The compounds 4a and 4c expressed 
emphatic activity against S. Aureus. Compounds 4b and 4d have showed more antibacterial activity against E. 
Coli, whereas compounds 4d exhibited considerable activity against  Klebsiella. In general, increasing the 
concentration of solutions, their antibacterial activity has increased. 
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